It is possible that a longer period of follow-up would be required for any differences in HCRU related to therapeutic potency to manifest, and this is a possibility worthy of further study
With human analogs (liraglutide, semaglutide), the rates of anti-drug antibodies are much lower (around 58%) and high titers are rare
Higher BMI levels may be associated with increased risk of type 2 diabetes, high blood pressure, heart disease, sleep apnea, fatty liver disease, joint pain, and metabolic conditions
MFC-MSNs can be used as drug delivery vehicles to enhance therapeutic effects through sustained release of methotrexate (MTX)
DSIP has been studied in human clinical settings for decades, with research examining its effects on sleep disorders, stress-related insomnia, and recovery in high-demand populations